A citation-based method for searching scientific literature

Marc Remke, Thomas Hielscher, Paul A Northcott, Hendrik Witt, Marina Ryzhova, Andrea Wittmann, Axel Benner, Andreas von Deimling, Wolfram Scheurlen, Arie Perry, Sidney Croul, Andreas E Kulozik, Peter Lichter, Michael D Taylor, Stefan M Pfister, Andrey Korshunov. J Clin Oncol 2011
Times Cited: 162







List of co-cited articles
704 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Molecular subgroups of medulloblastoma: the current consensus.
Michael D Taylor, Paul A Northcott, Andrey Korshunov, Marc Remke, Yoon-Jae Cho, Steven C Clifford, Charles G Eberhart, D Williams Parsons, Stefan Rutkowski, Amar Gajjar,[...]. Acta Neuropathol 2012
61

Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas.
Marcel Kool, Andrey Korshunov, Marc Remke, David T W Jones, Maria Schlanstein, Paul A Northcott, Yoon-Jae Cho, Jan Koster, Antoinette Schouten-van Meeteren, Dannis van Vuurden,[...]. Acta Neuropathol 2012
585
55

Medulloblastoma comprises four distinct molecular variants.
Paul A Northcott, Andrey Korshunov, Hendrik Witt, Thomas Hielscher, Charles G Eberhart, Stephen Mack, Eric Bouffet, Steven C Clifford, Cynthia E Hawkins, Pim French,[...]. J Clin Oncol 2011
818
43

Intertumoral Heterogeneity within Medulloblastoma Subgroups.
Florence M G Cavalli, Marc Remke, Ladislav Rampasek, John Peacock, David J H Shih, Betty Luu, Livia Garzia, Jonathon Torchia, Carolina Nor, A Sorana Morrissy,[...]. Cancer Cell 2017
447
41

Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.
Marcel Kool, David T W Jones, Natalie Jäger, Paul A Northcott, Trevor J Pugh, Volker Hovestadt, Rosario M Piro, L Adriana Esparza, Shirley L Markant, Marc Remke,[...]. Cancer Cell 2014
432
39

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
38

Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma.
Nataliya Zhukova, Vijay Ramaswamy, Marc Remke, Elke Pfaff, David J H Shih, Dianna C Martin, Pedro Castelo-Branco, Berivan Baskin, Peter N Ray, Eric Bouffet,[...]. J Clin Oncol 2013
251
36

Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups.
David W Ellison, James Dalton, Mehmet Kocak, Sarah Leigh Nicholson, Charles Fraga, Geoff Neale, Anna M Kenney, Dan J Brat, Arie Perry, William H Yong,[...]. Acta Neuropathol 2011
325
34

Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032.
Giles W Robinson, Brent A Orr, Gang Wu, Sridharan Gururangan, Tong Lin, Ibrahim Qaddoumi, Roger J Packer, Stewart Goldman, Michael D Prados, Annick Desjardins,[...]. J Clin Oncol 2015
225
33

Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.
Yoon-Jae Cho, Aviad Tsherniak, Pablo Tamayo, Sandro Santagata, Azra Ligon, Heidi Greulich, Rameen Berhoukim, Vladimir Amani, Liliana Goumnerova, Charles G Eberhart,[...]. J Clin Oncol 2011
453
32

Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features.
Marcel Kool, Jan Koster, Jens Bunt, Nancy E Hasselt, Arjan Lakeman, Peter van Sluis, Dirk Troost, Netteke Schouten-van Meeteren, Huib N Caron, Jacqueline Cloos,[...]. PLoS One 2008
491
32

Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.
Vijay Ramaswamy, Marc Remke, Eric Bouffet, Simon Bailey, Steven C Clifford, Francois Doz, Marcel Kool, Christelle Dufour, Gilles Vassal, Till Milde,[...]. Acta Neuropathol 2016
275
31

Subgroup-specific structural variation across 1,000 medulloblastoma genomes.
Paul A Northcott, David J H Shih, John Peacock, Livia Garzia, A Sorana Morrissy, Thomas Zichner, Adrian M Stütz, Andrey Korshunov, Jüri Reimand, Steven E Schumacher,[...]. Nature 2012
542
30

Cytogenetic prognostication within medulloblastoma subgroups.
David J H Shih, Paul A Northcott, Marc Remke, Andrey Korshunov, Vijay Ramaswamy, Marcel Kool, Betty Luu, Yuan Yao, Xin Wang, Adrian M Dubuc,[...]. J Clin Oncol 2014
162
30

Subtypes of medulloblastoma have distinct developmental origins.
Paul Gibson, Yiai Tong, Giles Robinson, Margaret C Thompson, D Spencer Currle, Christopher Eden, Tanya A Kranenburg, Twala Hogg, Helen Poppleton, Julie Martin,[...]. Nature 2010
512
29

Molecular subgroups of adult medulloblastoma: a long-term single-institution study.
Fu Zhao, Hiroko Ohgaki, Lei Xu, Felice Giangaspero, Chunde Li, Peng Li, Zhijun Yang, Bo Wang, Xingchao Wang, Zhenmin Wang,[...]. Neuro Oncol 2016
50
58

Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct.
Paul A Northcott, Thomas Hielscher, Adrian Dubuc, Stephen Mack, David Shih, Marc Remke, Hani Al-Halabi, Steffen Albrecht, Nada Jabado, Charles G Eberhart,[...]. Acta Neuropathol 2011
141
28

Long-term results of a prospective study on the treatment of medulloblastoma in adults.
Alba A Brandes, Enrico Franceschi, Alicia Tosoni, Valeria Blatt, Mario Ermani. Cancer 2007
86
31

The whole-genome landscape of medulloblastoma subtypes.
Paul A Northcott, Ivo Buchhalter, A Sorana Morrissy, Volker Hovestadt, Joachim Weischenfeldt, Tobias Ehrenberger, Susanne Gröbner, Maia Segura-Wang, Thomas Zichner, Vasilisa A Rudneva,[...]. Nature 2017
408
27

Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations.
Margaret C Thompson, Christine Fuller, Twala L Hogg, James Dalton, David Finkelstein, Ching C Lau, Murali Chintagumpala, Adekunle Adesina, David M Ashley, Stewart J Kellie,[...]. J Clin Oncol 2006
475
26

Novel mutations target distinct subgroups of medulloblastoma.
Giles Robinson, Matthew Parker, Tanya A Kranenburg, Charles Lu, Xiang Chen, Li Ding, Timothy N Phoenix, Erin Hedlund, Lei Wei, Xiaoyan Zhu,[...]. Nature 2012
537
25

Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
Roger J Packer, Amar Gajjar, Gilbert Vezina, Lucy Rorke-Adams, Peter C Burger, Patricia L Robertson, Lisa Bayer, Deborah LaFond, Bernadine R Donahue, MaryAnne H Marymont,[...]. J Clin Oncol 2006
552
25

Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.
Edward C Schwalbe, Janet C Lindsey, Sirintra Nakjang, Stephen Crosier, Amanda J Smith, Debbie Hicks, Gholamreza Rafiee, Rebecca M Hill, Alice Iliasova, Thomas Stone,[...]. Lancet Oncol 2017
221
24

Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449.
Charles M Rudin, Christine L Hann, John Laterra, Robert L Yauch, Christopher A Callahan, Ling Fu, Thomas Holcomb, Jeremy Stinson, Stephen E Gould, Barbara Coleman,[...]. N Engl J Med 2009
747
23

Dissecting the genomic complexity underlying medulloblastoma.
David T W Jones, Natalie Jäger, Marcel Kool, Thomas Zichner, Barbara Hutter, Marc Sultan, Yoon-Jae Cho, Trevor J Pugh, Volker Hovestadt, Adrian M Stütz,[...]. Nature 2012
565
23

Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study.
Carsten Friedrich, André O von Bueren, Katja von Hoff, Robert Kwiecien, Torsten Pietsch, Monika Warmuth-Metz, Peter Hau, Frank Deinlein, Joachim Kuehl, Rolf D Kortmann,[...]. Eur J Cancer 2013
59
38

Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis.
Eric M Thompson, Thomas Hielscher, Eric Bouffet, Marc Remke, Betty Luu, Sridharan Gururangan, Roger E McLendon, Darell D Bigner, Eric S Lipp, Sebastien Perreault,[...]. Lancet Oncol 2016
142
23

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
Amar Gajjar, Murali Chintagumpala, David Ashley, Stewart Kellie, Larry E Kun, Thomas E Merchant, Shaio Woo, Greg Wheeler, Valerie Ahern, Matthew J Krasin,[...]. Lancet Oncol 2006
567
22


Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples.
Paul A Northcott, David J H Shih, Marc Remke, Yoon-Jae Cho, Marcel Kool, Cynthia Hawkins, Charles G Eberhart, Adrian Dubuc, Toumy Guettouche, Yoslayma Cardentey,[...]. Acta Neuropathol 2012
240
21

Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification.
Andrey Korshunov, Marc Remke, Wiebke Werft, Axel Benner, Marina Ryzhova, Hendrik Witt, Dominik Sturm, Andrea Wittmann, Anna Schöttler, Jörg Felsberg,[...]. J Clin Oncol 2010
104
21

Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis.
Vijay Ramaswamy, Marc Remke, Eric Bouffet, Claudia C Faria, Sebastien Perreault, Yoon-Jae Cho, David J Shih, Betty Luu, Adrian M Dubuc, Paul A Northcott,[...]. Lancet Oncol 2013
211
21

Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults.
Laetitia Padovani, Marie-Pierre Sunyach, David Perol, Cedric Mercier, Claire Alapetite, Christine Haie-Meder, Sylvette Hoffstetter, Xavier Muracciole, Christine Kerr, Jean-Philippe Wagner,[...]. Int J Radiat Oncol Biol Phys 2007
96
21

Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations.
Trevor J Pugh, Shyamal Dilhan Weeraratne, Tenley C Archer, Daniel A Pomeranz Krummel, Daniel Auclair, James Bochicchio, Mauricio O Carneiro, Scott L Carter, Kristian Cibulskis, Rachel L Erlich,[...]. Nature 2012
516
20

FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma.
Marc Remke, Thomas Hielscher, Andrey Korshunov, Paul A Northcott, Sebastian Bender, Marcel Kool, Frank Westermann, Axel Benner, Huriye Cin, Marina Ryzhova,[...]. J Clin Oncol 2011
120
20

Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07).
Dagmar Beier, Martin Proescholdt, Christiane Reinert, Torsten Pietsch, David T W Jones, Stefan M Pfister, Elke Hattingen, Clemens Seidel, Linda Dirven, Ralf Luerding,[...]. Neuro Oncol 2018
34
55

DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies.
Edward C Schwalbe, Daniel Williamson, Janet C Lindsey, Dolores Hamilton, Sarra L Ryan, Hisham Megahed, Miklós Garami, Peter Hauser, Bożena Dembowska-Baginska, Danuta Perek,[...]. Acta Neuropathol 2013
82
21

Adjuvant chemotherapy and overall survival in adult medulloblastoma.
Benjamin H Kann, Nataniel H Lester-Coll, Henry S Park, Debra N Yeboa, Jacqueline R Kelly, Joachim M Baehring, Kevin P Becker, James B Yu, Ranjit S Bindra, Kenneth B Roberts. Neuro Oncol 2017
32
56

Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables.
David W Ellison, Mehmet Kocak, James Dalton, Hisham Megahed, Meryl E Lusher, Sarra L Ryan, Wei Zhao, Sarah Leigh Nicholson, Roger E Taylor, Simon Bailey,[...]. J Clin Oncol 2011
190
17

Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis.
Steven C Clifford, Meryl E Lusher, Janet C Lindsey, Jacqueline A Langdon, Richard J Gilbertson, Debbie Straughton, David W Ellison. Cell Cycle 2006
170
17

MRI surrogates for molecular subgroups of medulloblastoma.
S Perreault, V Ramaswamy, A S Achrol, K Chao, T T Liu, D Shih, M Remke, S Schubert, E Bouffet, P G Fisher,[...]. AJNR Am J Neuroradiol 2014
132
17


Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.
R J Packer, J Goldwein, H S Nicholson, L G Vezina, J C Allen, M D Ris, K Muraszko, L B Rorke, W M Wara, B H Cohen,[...]. J Clin Oncol 1999
404
16

The treatment of adults with medulloblastoma: a prospective study.
Alba A Brandes, Mario Ermani, Pietro Amista, Umberto Basso, Francesca Vastola, Marina Gardiman, Paolo Iuzzolino, Sergio Turazzi, Antonino Rotilio, Lorenzo Volpin,[...]. Int J Radiat Oncol Biol Phys 2003
55
29

The 2007 WHO classification of tumours of the central nervous system.
David N Louis, Hiroko Ohgaki, Otmar D Wiestler, Webster K Cavenee, Peter C Burger, Anne Jouvet, Bernd W Scheithauer, Paul Kleihues. Acta Neuropathol 2007
16

Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma.
Paul A Northcott, Catherine Lee, Thomas Zichner, Adrian M Stütz, Serap Erkek, Daisuke Kawauchi, David J H Shih, Volker Hovestadt, Marc Zapatka, Dominik Sturm,[...]. Nature 2014
318
16

Medulloblastomics: the end of the beginning.
Paul A Northcott, David T W Jones, Marcel Kool, Giles W Robinson, Richard J Gilbertson, Yoon-Jae Cho, Scott L Pomeroy, Andrey Korshunov, Peter Lichter, Michael D Taylor,[...]. Nat Rev Cancer 2012
390
16

beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee.
David W Ellison, Olabisi E Onilude, Janet C Lindsey, Meryl E Lusher, Claire L Weston, Roger E Taylor, Andrew D Pearson, Steven C Clifford. J Clin Oncol 2005
287
15

Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays.
Volker Hovestadt, Marc Remke, Marcel Kool, Torsten Pietsch, Paul A Northcott, Roger Fischer, Florence M G Cavalli, Vijay Ramaswamy, Marc Zapatka, Guido Reifenberger,[...]. Acta Neuropathol 2013
180
15



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.